Profund Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $384K | Sell |
|
|||||
|
2024
Q4 | $395K | Sell |
|
|||||
|
2024
Q3 | $441K | Sell |
|
|||||
|
2024
Q2 | $457K | Sell |
|
|||||
|
2024
Q1 | $766K | Buy |
|
|||||
|
2023
Q4 | $784K | Sell |
|
|||||
|
2023
Q3 | $632K | Buy |
|
|||||
|
2023
Q2 | $696K | Sell |
|
|||||
|
2023
Q1 | $610K | Buy |
|
|||||
|
2022
Q4 | $434K | Buy |
|
|||||
|
2022
Q3 | $359K | Sell |
|
|||||
|
2022
Q2 | $441K | Buy |
|
|||||
|
2022
Q1 | $461K | Buy |
|
|||||
|
2021
Q4 | $368K | Buy |
|
|||||
|
2021
Q3 | $252K | Sell |
|
|||||
|
2021
Q2 | $298K | Buy |
|
|||||
|
2021
Q1 | $227K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $138K | Sell |
|
|||||
|
2018
Q3 | $323K | Buy |
|